Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jildou Sijbrandij

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pharmacy World & Science : PWS|October 31, 2003
Changing relationships: attitudes and opinions of general practitioners and pharmacists regarding the role of the community pharmacistPaul E Muijrers, J André Knottnerus, Jildou Sijbrandij, et al.
Pharmacy World & Science : PWS|November 18, 2006
Pharmaceutical care and its relationship to prescribing behaviour of general practitionersPaul E M Muijrers, Richard P T M Grol, Jildou Sijbrandij, et al.
Family Practice|August 2, 2005
Differences in prescribing between GPs: impact of the cooperation with pharmacists and impact of visits from pharmaceutical industry representativesPaul E M Muijrers, Richard P T M Grol, Jildou Sijbrandij, et al.
Pharmacy World & Science : PWS|December 16, 2004
Pharmacists in primary care. Determinants of the care-providing function of Dutch community pharmacists in primary carePaul E M Muijrers, J André Knottnerus, Jildou Sijbrandij, et al.
European Journal of Clinical Pharmacology|November 2, 2004
Prescribing indicators. Development and validation of guideline-based prescribing indicators as an instrument to measure the variation in the prescribing behaviour of general practitionersPaul E M Muijrers, Rob Janknegt, Jildou Sijbrandij, et al.
World Journal of Gastroenterology|January 27, 2006
Internet-based data inclusion in a population-based European collaborative follow-up study of inflammatory bowel disease patients: description of methods used and analysis of factors influencing response ratesFrank L Wolters, Gilbert van Zeijl, Jildou Sijbrandij, et al.
JAMA|May 15, 2003
Effect of a practice-based strategy on test ordering performance of primary care physicians: a randomized trialWim H J M Verstappen, Trudy van der Weijden, Jildou Sijbrandij, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 1, 2004
Environmental exposure reduction in high-risk newborns: where do we start?Hubert J A M Schönberger, Tanja Maas, Edward Dompeling, et al.
Scandinavian Journal of Gastroenterology. Supplement|June 20, 2006
Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up studyFrank L Wolters, Maurice G Russel, Jildou Sijbrandij, et al.
Gastroenterology|September 6, 2006
Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluationSelwyn Odes, Hillel Vardi, Michael Friger, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pharmacy World & Science : PWS|October 31, 2003
Changing relationships: attitudes and opinions of general practitioners and pharmacists regarding the role of the community pharmacistPaul E Muijrers, J André Knottnerus, Jildou Sijbrandij, et al.
Pharmacy World & Science : PWS|November 18, 2006
Pharmaceutical care and its relationship to prescribing behaviour of general practitionersPaul E M Muijrers, Richard P T M Grol, Jildou Sijbrandij, et al.
Family Practice|August 2, 2005
Differences in prescribing between GPs: impact of the cooperation with pharmacists and impact of visits from pharmaceutical industry representativesPaul E M Muijrers, Richard P T M Grol, Jildou Sijbrandij, et al.
Pharmacy World & Science : PWS|December 16, 2004
Pharmacists in primary care. Determinants of the care-providing function of Dutch community pharmacists in primary carePaul E M Muijrers, J André Knottnerus, Jildou Sijbrandij, et al.
European Journal of Clinical Pharmacology|November 2, 2004
Prescribing indicators. Development and validation of guideline-based prescribing indicators as an instrument to measure the variation in the prescribing behaviour of general practitionersPaul E M Muijrers, Rob Janknegt, Jildou Sijbrandij, et al.
World Journal of Gastroenterology|January 27, 2006
Internet-based data inclusion in a population-based European collaborative follow-up study of inflammatory bowel disease patients: description of methods used and analysis of factors influencing response ratesFrank L Wolters, Gilbert van Zeijl, Jildou Sijbrandij, et al.
JAMA|May 15, 2003
Effect of a practice-based strategy on test ordering performance of primary care physicians: a randomized trialWim H J M Verstappen, Trudy van der Weijden, Jildou Sijbrandij, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 1, 2004
Environmental exposure reduction in high-risk newborns: where do we start?Hubert J A M Schönberger, Tanja Maas, Edward Dompeling, et al.
Scandinavian Journal of Gastroenterology. Supplement|June 20, 2006
Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up studyFrank L Wolters, Maurice G Russel, Jildou Sijbrandij, et al.
Gastroenterology|September 6, 2006
Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluationSelwyn Odes, Hillel Vardi, Michael Friger, et al.
Pageof 2